Near-infrared dye IRDye800CW-NHS coupled to Trastuzumab for near-infrared II fluorescence imaging in tumor xenograft models of HER-2-positive breast cancer

The NIR-II fluorescent probe Trastuzumab-800CW was used for NIR-II fluorescent targeting of HER-2-positive breast cancer tumors and was systematically compared with Trastuzumab-ICG.